Podcasts about Royal London Hospital

Up to 40% of cancers are attributable to modifiable risk factors, including diet, obesity, alcohol, tobacco use, and physical inactivity. The WCRF estimates that about 1 in 3 cancer cases in high-income countries could be prevented by healthier diets, maintaining a healthy weight, and regular physical activity. And according to the National Cancer Institute in the US, physical inactivity is a recognized risk factor for colon, breast, and endometrial cancer.But even with the best intentions there's a lot of confusion around lifestyle and cancer. One day it's red meat, the next it's microwaves. We hear about them in headlines, social media posts or passed around in conversation, which can make it really hard to know what matters most.I'm joined today by Professor Robert Thomas, an NHS oncologist and researcher who's spent decades studying how lifestyle (from food and movement to gut health and supplements) affects cancer risk and recovery. We talk about …

Help us make this podcast better for you! Our quick listener survey is your chance to shape the next season: https://bit.ly/madeforuspod---When science journalist Layal Liverpool was finally diagnosed with eczema as a teenager, it came as a shock. Not because of the condition itself, but because only one doctor had recognized it on her skin tone.Pediatrician Tessa Davis had a similar wake-up call: she noticed that a Google search for common skin conditions only returned images of white patients. So she started collecting images of conditions on diverse skin tones, and launched a movement in the process.In this episode, Layal Liverpool, author of Systemic: How Racism is Making Us Ill, and Tessa Davis, a consultant at the Royal London Hospital, shed light on how racial inequities show up in diagnosis, treatment and outcomes — and how more inclusive care can lead to better health for all. We discuss:How racial health inequities harm not just marginalised communities, but all of usThe alarming disparities in maternal health in the UK and US that can't be explained by income aloneThe lack of diversity in medical textbooks and efforts to diversify the medical curriculumIf you found this episode as eye-opening as we did, share it with a friend and leave us a 5-star review on Apple Podcasts or Spotify to spread the word!---About Layal Liverpool:Layal Liverpool is a science journalist and author of SYSTEMIC: How Racism is Making Us Ill,' a book exploring the health harms of racism. She was a reporter for Nature and New Scientist and worked as a biomedical researcher at University College London and the University of Oxford. She holds a PhD in virology and immunology from the University of Oxford.Learn more about Layal Liverpool: https://layalliverpool.com/Follow Layal Liverpool on InstagramAbout Tessa Davis:Tessa is a Paediatric Emergency Medicine Consultant at the Royal London Hospital, and an Honorary Clinical Reader at Queen Mary University of London. She is also an interview coach helping doctors in the UK prep for their NHS Consultant Interviews.Learn more about Skin Deep: www.DFTBSkinDeep.comFollow Tessa on Instagram---Connect with Made for UsShow notes and transcripts: https://made-for-us.captivate.fm/ Social media: LinkedIn and InstagramNewsletter: https://madeforuspodcast.beehiiv.com/

In episode two of our Out of Programme (OOP) mini-series, we speak to Dr Wenhao Li, an ST6 Hepatology ACL at the Royal London Hospital. Wenhao shares his unforgettable OOP experience - spending a mont in the US on a BSG funded travelling fellowship. He takes us through his time in San Diego at the AASLD Liver Meeting, and the MASLD Research Centre. He also shared insights in to attending the EASL masterclass in Savannah. Keep an eye on your inbox for the weekly BSG newsletter, and get yourself to San Diego! Links: - https://www.bsg.org.uk/news/bsg-san-diego-travelling-fellowship-report Enjoying the podcast? Leave us a review on Apple (apple.co/3vCPuaz) or Spotify (spoti.fi/48y8oho). Get in touch with us at @BSGTrainees on Twitter.

Thriving in Pediatric Emergency Medicine: Insights from Dr. Tessa DavisIn this episode of The Girl Doc Survival Guide, we are joined by Dr. Tessa Davis, a pediatric emergency medicine consultant at the Royal London Hospital and co-founder of the pioneering educational platform Don't Forget the Bubbles. Dr. Davis shares her unique journey from Glasgow to Sydney and back to the UK, detailing her experiences in building a balanced and sustainable career. She offers practical advice on medical interviews, public speaking, and leveraging technology effectively. Additionally, Dr. Davis discusses the importance of mindset, self-advocacy, and fostering supportive professional teams for career success. She also highlights the challenges and strategies for managing high-stress situations and balancing family life, including raising three kids and two dogs. This conversation is a rich resource for anyone looking to excel in pediatrics or any demanding medical field.00:00 Introduction to Dr. Tessa Davis00:55 Tessa's Journey to Sydney01:57 Founding Don't Forget the Bubbles05:08 Balancing Roles and Responsibilities05:34 Mastering Medical Interviews13:28 Challenges in Pediatric Emergency Medicine14:27 Building a Sustainable Career22:19 Embracing Failure and Learning25:35 Final Reflections

In this episode of the Pre-Hospital Care Podcast, we are focusing on the vital topic of paediatric assessment in the pre-hospital phase of care. Assessing and managing a sick or injured child is one of the most challenging scenarios for pre-hospital teams. Our guest breaks down the key components of paediatric assessment with the subtle red flags that may indicate a child is critically unwell. We'll also explore practical approaches to airway management, assessing breathing and circulation, and understanding neurological status in children of all ages.Beyond the clinical side, we discuss the softer skills required when working with paediatric patients, like engaging with caregivers, managing a child's fear, and staying calm under pressure. Whether you're new to pre-hospital care or an experienced provider looking to refine your skills, this episode will provide valuable insights and actionable takeaways. Anna Dobbie is a consultant in emergency medicine at The Royal London Hospital and the lead clinician with London's Air Ambulance. With a special interest in paediatrics and teaching, Anna plays a key role in advancing pre-hospital care. In this episode, we explore her journey, insights, and experiences in emergency and pre-hospital paediatric medicine.* Please note, the content of this podcast is for information purposes only. Please stay within your scope of practice and services operating practices at all times * This podcast is sponsored by PAX.Whatever kind of challenge you have to face - with PAX backpacks you are well-prepared. Whether on water, on land or in the air - PAX's versatile, flexible backpacks are perfectly suitable for your requirements and can be used in the most demanding of environments. Equally, PAX bags are built for comfort and rapid access to deliver the right gear at the right time to the right patient. To see more of their innovative designed product range, please click here:⁠https://www.pax-bags.com/en/⁠

All fresh back from the latest EPOS meeting in Toulouse! We Welcome listeners back to the 12th EPISODE of the BSCOS Paediatric Orthopaedic Digest (POD)cast with special guest Darius Rad of Southampton Childrens Hospital! Heradling from Transylavania in Romania, he trained at Royal London Hospital, Great Ormond Street and Noah's Ark Children's Hospital for Wales before being appointed as a consultant in Southampton where hei s part of a growing team! His favourite poem is The Road Not Taken by Robert Frost: “I shall be telling this with a sigh, Somewhere ages and ages hence: Two roads diverged in a wood, and I—I took the one less travelled by, And that has made all the difference.” We scoured 35 journals & highlighted the most impactful studies that we feel can change practice or improve outcomes in Paediatric Orthopaedics. Also…we play EURO-HOT or EURO-NOT so stay tuned and be educated on 90's European Dance Music!Follow Updates on @BSCOS_UK on X / Instagram!REFERENCES:1.    Autism screening and diagnostic outcomes among toddlers born preterm. Hamner et al. Dev Med Child Neurol. March 2025. PMID: 39165130 2.    The effect of vitamin D on the speed and quality of pediatric fracture healing. Hendrych et al. J Child Orthop. November 2024. PMID: 39563984 3.    Spontaneous recovery in the majority of stable dysplastic hips treated with active surveillance. Theunissen et al. Bone Joint J. February 2025. PMID: 39889762. 4.    Proximal versus distal tenotomy of the iliopsoas tendon in the surgical treatment of developmental dysplasia of the hip: a randomized clinical trial. Doski J. Int Orthop. March 2025. PMID: 39853427. 5.     Intraoperative Tranexamic Acid Infusion Reduces Perioperative Blood Loss in Pediatric Limb-Salvage Surgeries: A Double-Blinded Randomized Placebo-Controlled Trial. El Ghoneimy et al. J Bone Joint Surg Am. March 2025.  PMID: 39841811. 6.     Morphological Improvement of the Epiphyseal Plate and Trochlea After Surgical Correction in Skeletally Immature Patients With Patellar Dislocation and Trochlear Dysplasia. Hao et al.  Am J Sports Med. February 2025. PMID: 39743963. 7.     Dexterity assessment of hospital workers: prospective comparative study. Joseph et al. BMJ. December 2024. PMID: 39706594. 8.     Subtalar arthroereisis with metallic implant is a safe and effective treatment for pediatric patients with symptomatic flexible flatfeet. A 10-year clinical and radiographic follow-up. Moraca et al. Foot Ankle Surg. Jan 2025. PMID: 38972783 9.     The risk of refracture and malunion in children treated for diaphyseal forearm fractures: a retrospective cohort study. Husum et al. Acta Orthop. Feburary 2025. PMID: 39993177; 10.  Optimal Timing for Advanced Imaging in Childhood Bone and Joint Infection. Hunter et al. J Pediatr Orthop. Feburary 2025. PMID: 39307981. 11.  Get Over It: Surgical Residents' Responses to Simulated Harassment. A Multi Method Study. Johnson et al. J Surg Educ. March 2025. PMID: 39818080. 12.  Oral Infigratinib Therapy in Children with Achondroplasia. Savarirayan et al. N Engl J Med. February 2025. PMID: 39555818. 13.  From Sheep to Sling: Pediatric Injuries Due to Rodeo Mutton Bustin'. Schultz et al. J Pediatr Orthop.April 2025. PMID: 39831656. Follow Hosts: @AnishPSangh @AlpsKothari @Pranai_BTune in for the next episode in Summer! Have a fantastic Easter!

Do you remember what made you want to become a nurse? When things get tough at work, it can be helpful to reconnect with why you came to love nursing in the first place.So as the new year gets going and winter pressures put strain on the workforce, the Nursing Standard podcast brings three nurses together to talk about why they went into the profession and how they maintain their enthusiasm for work.Ana Waddington, a former RCN Nurse of the Year, is the paediatric critical care outreach team lead and Martha's Rule lead at the Royal London Hospital. She discusses how making the most of new opportunities keeps her motivated.Alder Hey Children's NHS Foundation Trust chief nursing officer Nathan Askew talks about how switching off from work and maintaining other passions helps to refresh his love for the job.And Harley Street Clinic lead radiotherapy clinical nurse specialist Jane Ewang describes the support and inspiration she receives from colleagues, both in her day job and in her work with the UK Oncology Nursing Society.The three tell Nursing Standard content editor and podcast host Alistair Mason some of the best advice they've received as nurses and offer tips on staying motivated when work is particularly tough.They also talk about the improvements they have seen in the profession over the course of their careers and highlight the things that are getting them excited for 2025.For more episodes of the Nursing Standard podcast, visit rcni.com/podcast Hosted on Acast. See acast.com/privacy for more information.

Do you remember what made you want to become a nurse? When things get tough at work, it can be helpful to reconnect with why you came to love nursing in the first place.So as the new year gets going and winter pressures put strain on the workforce, the Nursing Standard podcast brings three nurses together to talk about why they went into the profession and how they maintain their enthusiasm for work.Ana Waddington, a former RCN Nurse of the Year, is the paediatric critical care outreach team lead and Martha's Rule lead at the Royal London Hospital. She discusses how making the most of new opportunities keeps her motivated.Alder Hey Children's NHS Foundation Trust chief nursing officer Nathan Askew talks about how switching off from work and maintaining other passions helps to refresh his love for the job.And Harley Street Clinic lead radiotherapy clinical nurse specialist Jane Ewang describes the support and inspiration she receives from colleagues, both in her day job and in her work with the UK Oncology Nursing Society.The three tell Nursing Standard content editor and podcast host Alistair Mason some of the best advice they've received as nurses and offer tips on staying motivated when work is particularly tough.They also talk about the improvements they have seen in the profession over the course of their careers and highlight the things that are getting them excited for 2025.For more episodes of the Nursing Standard podcast, visit rcni.com/podcast Hosted on Acast. See acast.com/privacy for more information.

This episode features a conversation that explores the intersectionality of race, careers in engineering and joy. These are big topics on their own and become highly amplified and sometimes harmful, when one's self-identities and protected characteristics intertwine.  Today, we're going to approach them with care and mindful intention as these are themes that we don't often get to share in this way. My name is Beatrice Udeh and I am the guest host for this Black History Month episode of Impulse to Innovation.   Beatrice Udeh is Head of Diversity at the Arts Marketing Association (AMA). She is an award-winning creative specialist, a theatre producer, broadcaster & poet, and has held positions at both the BBC and Arts Council England. She has a degree in mechanical engineering and was a mechanical design engineer for Rolls Royce.   So, why am I hosting and not Dr Helen Meese? Well, Helen approached me as she was keen for the IMechE to celebrate Black History Month, but wanted to make sure that somebody with lived-experience and a professional EDI background was at the helm to hold the space for the panel. I'm no stranger to the IMechE or to the microphone. I'm a former broadcast journalist and radio producer. I'm a former Mechanical Design Engineer and was an IMechE member nigh on 25 years ago, chairing the Young Members Panel for Derby and Nottingham in the East Midlands. I am joined on the episode by some amazing people who are leaders in their technical and engineering fields including start-ups, geeks, policymakers and just plain, smart engineers. I'm excited to get to the pulse of what makes them rock and find out how they roll during BHM and beyond.   I wanted to share a few things as provocations for this discussion, here are some interesting stats by the Association of Black and Minority Ethnic Engineers (AFBE-UK): “Currently, around 30% of the U.K.'s engineering university graduates are from black and minority ethnic backgrounds. However, these underrepresented groups account for only 9% of professional engineers. This is largely due to the barriers and challenges these groups face in recruitment, retention, and advancing professional development.” With my Diversity-lead hat on, three things stick out for me. One, there is the language - black and minority ethnic. Two, the stats (30% of University graduates vs 9% entering the sector) and three the business case for a thriving workforce: recruitment, retention and career advancement.   According to Engineering UK, Global Majority individuals in the UK engineering sector face several specific challenges. Research has been done to quantify this, with specific examples of inclusion of people and inclusivity written into processes and policies. Not being seen aka representation  Different types of bias such as the halo effect, or conformity bias and even attribution bias. All of these biases impact our behaviours and lead to discrimination even before reaching the workplace, let alone in the recruitment, onboarding and retention processes. The National Engineering Policy Centre (NEPC), released a report this summer highlighting the importance of increasing representation in engineering and emphasising the need for a diverse and skilled workforce.  And with a reported 700,000 people contributing to the engineering economy and 'Statista Data' showing that there are 540,000 engineers working in the UK, what does this mean when we intersect this with Black-British history and Global Majority engineering futures?    This months guests are:   Swati Swati is a dedicated, award-winning Biomedical Engineer. Having moved from India  where she worked at the Ministry of Health and Family Welfare, she studied for her engineering degree before starting a new career as a Clinical Technologist at Royal London Hospital, Barts Health NHS Trust. With a passion for STEM education and Healthcare Swati has set up her own company and now provides a variety of leadership, technical and regulatory affairs courses for students at universities and healthcare related solutions to hospitals and healthcare industries.   Dr Nike Folayan MBE is a chartered engineer and Fellow of the IET. She holds a PhD in Electronics Engineering with referenced international research publications and citations. She sits on a number of advisory boards for various governmental and non-governmental organisations including the Royal Academy of Engineering, Transport for London and  the University of Kent Industrial Panel. Nike is recognised as one of the top 100 most influential women in engineering and recieved her MBE for services to diversity in engineering in 2020. Nike is co-founder and chairperson of AFBE-UK, a UK-wide organisation that promotes higher achievement in Engineering particularly for underrepresented groups in engineering. She is presently Technical Director at WSP UK.   Shefali Sharma is an Aeronautics & Space Engineer and Co-Founder & Director of Oxford Dynamics. Seconded to India on behalf of the UK space industry & the Dept. for International Trade in her early career, Shefali has gone on to become a leading Entrepreneur in the space sector creating OxLABS and Oxford Dynamics in less than five years. With multiple honours to her name, she is now focusing on cutting-edge Artificial Intelligence research for the space industry.     Dr Bridget Ogwezi is an award winning doctoral research engineer and civil engineering graduate. She is Senior Strategic Project Manager for Ansys UK. Bridget is passionate about the process of discovery in particular, how to harness human innovation, technology and the materials we build with to make buildings healthier and less damaging to the planet.     Maira Bana is a chartered mechanical engineer with expertise in analysing and resolving cooling and airflow challenges in the data centre industry, through thermal simulation. She manages the CFD Team at RED Engineering Design. Maira is an active IMechE volunteer and Co-Chairs the Construction & Building Services Division, she is also a past Trustee of the Institution. Presently she is a Trustee of SheCanEngineer.     Useful Links: Assoc. for Black & Minority Ethnic Engineers UK SheCanEngineer The Hamilton Commission Mission 44 IMechE DEI Information     We would love to hear your thoughts and comments on this episode. If you would like to get in touch, email us at podcast@imeche.org You can find more information about the work of the IMechE at www.imeche.org   

For Sickle Cell Awareness Month, our sickle cell Patient Voice Group discuss their lived experiences with sickle cell, shedding light on how organisations need to be considerate when engaging with patients. They emphasise the need for genuine engagement and transparency from researchers, while highlighting the importance of building trust within communities that have historically been overlooked. The discussion looks to the future, advocating for more personalised support, better treatment options and a stronger focus on the diverse experiences of those affected by sickle cell. Marie Nugent, Community Manager for the Genomics England Diverse Data Initiative co-hosts this episode with Natasha Gordon-Douglas, sickle cell patient advocate for the Genomics England Diverse Data Initiative and Lead Mentor at the Sickle Cell Society. They are joined by Oleander Agbetu, who cares for her son with sickle cell, and is also a member of the Solace sickle cell and thalassaemia support group board, and Jayson Kupoluyi, sickle cell advocate and volunteer for the Sickle Cell Society. The episode also features insights from some of the other members of the Patient Voice Group; Hazel Attua, Samuel Chuku and Zainab Garba-Sani. The Patient Voice Group are a group of people affected by sickle cell who share with Genomics England their expertise, based on their lived experience, to inform our sickle cell programme within the Diverse Data Initiative.   "If we as parent/carers and advocates and all the rest of it can even make a little slight difference to someone's care, that's what I want to do. That's why I'm here."   You can read the transcript below or download it here: https://www.genomicsengland.co.uk/assets/documents/Podcast-transcripts/How-can-organisations-support-those-living-with-sickle-cell-1.docx  Marie: Welcome to Behind the Genes.  Natasha: I think the fact is that people do want to hear from patients, and they do understand that actually you need the patient's voice in order to make things better, and not just be in a room where you've got all board members that think, “Okay, this is what is good for the patient.” No, actually, they've got the patients there to help support that voice, and saying, “Well actually, this is the reality,” rather than what you think might be the reality.  Marie: My name is Marie Nugent and I'm the community manager for diverse data at Genomics England. I'll be co-hosting today's special patient takeover episode of Behind the Genes with Natasha Gordon-Douglas, who is a member of our sickle cell patient voice group. On this episode, we're going to be speaking to two people who are also part of our patient voice group, Oleander Agbetu and Jayson Kupoluyi. Today we'll be discussing what it's like to live with sickle cell, and how organisations who wish to engage with patients need to be considerate of what is going on in people's lives, and what good advocacy and support for patients who want to be involved in research looks like. If you enjoy today's episode, we would love your support. Please like and share, and rate us on wherever you listen to your podcasts.  Welcome everyone, thank you very much for your time today to talk about the patient involvement and engagement work we've been doing as part of our sickle cell and genomics programme at Genomics England. My name's Marie, I'm the community manager for the diverse data initiative, and I am really involved in doing the sickle cell engagement work. I'm going to pass straight to Natasha now, who's going to be my lovely co-host for this podcast. So, over to you, Natasha.  Natasha: Thank you, Marie. I'm Natasha. I would say my background is nothing to do with the medical side. My background is in marketing and the corporate world. That's how actually I got introduced by John James, because I actually got him into our workplace to do a podcast about sickle cell. So, you know, just – I'm working in an environment, which obviously – it's about people understanding about my illness, so I actually got him in speaking, and then he mentioned about a project, “Oh, you might be interested in this.” So, that was kind of the introduction I got from John James. But as I said, doing patient work and engagement stuff was completely new to me, so this is my – I'm a rookie, I should say. But I feel like now after the two years, I know now, I understand [laughter]. But yeah, that's kind of a quick background. And how I got introduced to Marie is from John James at the Sickle Cell Society.  Marie: Great, thank you, Natasha. So, coming straight to you now, Oleander, I think it's a bit different for you. So, you joined this particular group not too long ago, but from what I know, you've been doing this kind of advocacy work and engagement work for quite a while. So, tell us a bit about yourself.  Oleander: Well, I'm a parent/carer of a teenager, young man with sickle cell, and I think I've been part of the Solace sickle cell and thalassaemia support group board for more than ten years now. And what we do is we support patients through our WhatsApp group, as well as through inviting different people to come and talk. We've had doctors, nurses, etc. And I have supported people who have called me personally to ask me questions, from advice, for help. Also written a letter to the hospital, which we are now working on with the hospital itself, to try and get things moving and make improvements for the patients who are actually patients there at Homerton Hospital and Royal London Hospital.  Marie: And then over to you, Jayson. So, similar to Oleander, you joined this group fairly recently actually, but just tell us a little bit about the kind of work that you've done before.  Jayson: My name's Jayson Kupoluyi. My background is totally different from the sickle cell background. Because of the plight that I have with my health, I now decided that I wanted to make a change, so I – unbeknown to me – I didn't know what advocacy was. I just – when I meet people, I ask them questions, and, you know, thankfully enough, they really try and help and support in terms of advising me and those kind of things. So, I took that advice on board, and through the years I've met fantastic people, i.e. Oleander and her son. I met her son during a trip – we took the kids to a trip for a week for self-discovery, self-awareness, teaching them how to cope, and probably to see where – you know, try to make them open up.  So, I now decided to volunteer for the Sickle Cell Society and give them seven years of my time, in which I've met fantastic kids and fantastic people. And through that, I've learnt to be able to teach people and the kids under 16 – well, I'm teaching from 26 year olds down to 13 year olds on how to advocate for themselves in hospital now. I teach the adults how to fill in application forms for PIP. I also write complaint letters and help them deal with complaints. And I also – sometimes I have the chance, from Royal London and Queen's Hospital, to enter and view the situation, and ask information from the patients, from the nurses, carers and things like that, to be able to compile my own findings. And all in all, it's been rewarding, because I just wanted to give back.  Marie: That's incredible, you know, because something that we've been talking about more recently as part of our sickle cell patient voice group is this idea of advocacy, and I'm just reminded that I'm with a great group of people to actually explore this because of the experience that you've got, so this is wonderful. Now, you've all just said you've got varying like degrees of previous experience of being part of advocacy work. Natasha, I'll come straight to you, what were your initial expectations as to what it would mean or look like to be part of like a patient voice group?   Natasha: To be honest, very sceptical [laughter]. I was like, “What are they really going to – are they really going to take our voice on board, and is it just another tick box that they could say, “Okay, we've funded a group for you to – with sickle cell,”” and I was very, yeah, sceptical. But actually I would now advocate for everybody to be part of a patient voice group. I think it's so important. And the collaboration that happens with all these different organisations as well that you open up your mind to – ‘cos I didn't know – you know, especially for this particular project that we're working on, you've got the James Lind Alliance, never knew this organisation existed. I think the fact is that people do want to hear from patients, and they do understand that actually you need the patient's voice in order to make things better, and not just be in a room where you've got all board members that think, “Okay, this is what is good for the patient.” No, actually they've got the patients there to help support that voice and saying, “Well actually, this is the reality, rather than what you think might be the reality.”  So yeah, I would definitely champion anybody regardless, even – yeah, you've got sickle cell, of course, but any kind of illness, if there's any kind of projects, trying to get involved, to really be able to try and shape what can happen. Because, you know, I guess what we're working on at the moment, the opportunities for development within sickle cell are endless. And yeah, it's just being part of that steering group, part of that voice to actually make change, especially with sickle cell. You know, it's one of the ones that has never had anything – hasn't had change for I don't know how many years - I'm going to give away my age, for at least 40-odd years, I'll say [laughter]. But yeah, so from what I can see, it's slowly now changing and we're in that wave, and I'm so excited to be part of that.  I know Oleander, so you with your son, you've obviously seen the kind of – if there has been change for you. I guess for me as a patient, I might see it slightly differently, whereas you as a carer, a parent, you might see it completely differently. So I guess for you, what would you say for a person who might be considering joining a patient group or a parent/carer group?  Oleander: I too was sceptical at first, but at the same time I can say that I'm really happy that I have been involved, because it means that all the information that I find out about that might be relevant to other parent/carers, I can pass that on, and vice versa. Any questions that they might have or issues that they might be going through, I can also get those considered. And I just think that it can be quite sad when a patient goes into hospital and they are on their own, they don't have anyone with them. And so for me, for example, when my son was in paediatrics, and I'm sure the two of you would also know that, the treatment is just very different to when you become an adult. I could see from my son's face, he just was not impressed with the adult care at all. And he more or less says, “Mummy, I'm not coming back to hospital unless it's really like a dire situation. I just don't want to go back.” And that's quite sad because really we're supposed to be able to support our loved ones in hospital. When they need the care, they absolutely need the care.  I actually spoke to a parent today of a young man in hospital right now. His PCA was failing, which is, you know, the pump that gives the medication, right? And they actually asked her, “Is he still in pain?” If he's been put on a PCA, how can you ask that question? So, you know, it's so good that she was there to advocate on his behalf. He couldn't even talk. And, you know, I know for my son also, when he's in really, really deep pain, he stops talking, just doesn't talk. And if he's there by himself, it's a real issue. And so, you know, I think from that point of view, all of these kinds of stories are really important to bring to forums like this, so that people can understand that of course, yes, it first affects the actual patient themselves, but it has a knock-on effect for the families, and the carers and the people that are involved with that person's care. So, if we as parent/carers and advocates and all the rest of it can even make a little slight difference to someone's care, that's what I want to do. That's why I'm here.  Marie: Thank you so much, Oleander. I think that's a really powerful story as well, and it just shows so – I couldn't help but think, as you were talking there, about this idea of – we use the word community quite a lot in this kind of engagement space, but I must admit, you know, I've been working in public engagement with health and research for well over ten years, and I must say that I really felt the sense of community in this sickle cell space, particularly with patients and the wider sort of community, and that feels like it's a really important part actually. And it kind of speaks to what Jayson mentioned about, you know, he's now reached this point in his own life where he wants to be actively kind of contributing back to the community. So, I'll come to you now, Jayson. Again, what was your expectations about joining a group like this, and what were you thinking when you joined? And how has that maybe transformed now? Or potentially not? How has your experience been so far?  Jayson: It's been great actually, pleasant people, likeminded people working towards a common goal. When I first heard about this group, I said to myself, “Do I have space for another WhatsApp group?” It's not because I don't have space on the phone. It's because getting calls in the middle of the night at the same time – and you can't turn it down sometimes, especially if it's in the family, ‘cos I have these people – I have - you know, it's in our family and it's very, very rampant. And when you say community, you can have a mother of your nephew, your niece call you, knowing fully well that you've gone through that, this sort of thing, what's going on, blah-blah-blah, “Okay, this is what you need to do. This is what you need to do.” Then getting to the hospital is another ballgame, do you understand? And you just have to say, “Okay, you know what, if I take a moment of my time and say, “I'll see you in the morning…”” I've had two incidents that I didn't make it, and it's a guilt trip to me, because I was thinking, “Hold on, if I had gone…” And then I was okay – if I wasn't feeling okay then, yeah, but I was okay. I was just tired.   And when I started, I was a one-man band, and I realised the last 20 years that it's definitely not going to work, hence the community comes in. And the time I tapped into this community, I met people – “Okay, so, you could help me out, you could help me out, you could help me out.” And the more I meet people, the more my voice goes bigger, louder and reaches more people that I want to reach. So, when I first met Hazel, she was in pain, so I called her and I was like, “Madam, you don't know me, but I know that you're in pain, are you okay?” And she goes, “No, I just wanted to sit down.” I just sat down beside her, didn't speak to her, just sat down, and she didn't utter a word, but she came to a conference and I'm thinking, if you're in pain, you know, okay, I'm the same – I just started explaining myself to her, “I have this, I've gone through this,” blah-blah-blah, and she was looking at me and she was like, “You don't look like (inaudible 0:15:54).”   So, meeting and coming to this group, my expectation was a bit elevated actually because, when I was speaking to Hazel, she said, “No, Jay, seriously, you need to be in this group because we need the other…” And I was like, “Not another one,” and blah-blah-blah. Hazel said to me, “Can you join the Solace group?” I was like, “Who's in it?” She goes, “Oleander.” I was like, “Oleander's good.” And everybody keeps on calling me, and I do appreciate that people want my advice sometimes, but this health is very precious to us. I am looking forward to greater things with this group. I am looking forward for us to reach some targets, some funding, some people out there, to be able to change so many things. And any time I see a sickle cell person in good health, no pain, no nothing, I give myself thumbs up. You don't want to see anybody in that kind of pain, and people don't recognise or have that empathy to share or say, “Just another sickler.”  Sickler, that's a word, hmm, I don't like it. So, whenever I go to hospital, Queen's or Royal London, they know, “Jayson, are you here to cause problem?” “As long as you answer the question, I will be fine. As long as we're okay, I'll be fine.” And, you know, we're now friends. In the midst of adversity, we're now friends.    Marie: There is just so much I think in what you've just said, and I think that again something that I'm really struck by – so obviously, you know, I don't come from any lived experience. I didn't have people in my life that I knew that had sickle cell before starting to work on this as part of my job. And something that I'm really struck by is, first and foremost, from the No One's Listening Report, the quite staggering evidence that, as a community of people, people living with and affected in some way by sickle cell are very neglected, and there's all sorts of complex layers of like challenges and difficulties that people have to deal with, and it seems to come from all sorts of places and all sorts of kind of parts of life.  I was just really struck by this really daunting situation actually to be put in. As someone who's part of, you know, let's be honest, quite a sort of – maybe quite far down the road in terms of direct benefits, like piece of work – so we're here, I'm part of an organisation that is interested in supporting research and providing good quality research data, and research is a really important part of this whole system, but again it's something that maybe will take five, ten-plus years before you're seeing any direct benefit from in terms of the data that we're creating.   But something that I'm really struck by is this idea of, if we know that there's going to be maybe a bit of a delay in the kind of benefits that we can bring to patients through the data that we're generating, how can I try and build in as much benefit right now for the people that we're engaging with and we can bring into this work right now? And that's something that we've talked about and we're about to initiate a bit of a project around exploring a bit further, but I just wonder if I can now come to you all and get your thoughts on what can organisations like Genomics England or other research based organisations – what in your view does being a good supporter or a good advocate for people living with sickle cell – what could that look like from a research organisation in your view? I'll come to you first, Oleander.  Oleander: I think a really massive thing is to support the removal of barriers. There's so many people who would love to get involved with this, that and the other, but actually the barriers are there and the barriers are real. Even like from a personal point of view, the thing I was interested in attending, I can't. It's just not within my means. So, things like that are really important, because most people who are living with sickle cell, we are from marginalised groups. We're from groups that are not known to be flushed, and we need the support from – you know, if you really want our help in terms of research and so on, we absolutely need your support and your help to provide you with that research and that help. So, it's real. Giving someone a £20 voucher is nice and dandy, but actually if they've had to pay for whatever, accommodation or travel costs and all these things, they're out of pocket before they even start.  Marie: Yeah, this is something that we've been talking about recently, isn't it? I know that organisations like ours do want to do better, but sometimes there's just that not quite as good an understanding as to what these barriers really look like for people. Over to you, Natasha, what do you think about that?  Natasha: There's a couple of things I wanted to pick up on. One is definitely, yeah, the barriers. It's funny, I was at a hospital this morning and I was talking to one of the consultants. He asked me the question, which I thought was quite weird, but he asked me, “Why do you think that sickle cell patients have to pay for prescriptions?” Like that alone, prescriptions, we're on medication forever, you know, from the moment you're diagnosed, which for me was at six months, so in my entire life, and you're paying for prescription, that's going to keep happening over and over, and you're just – you know, there's people, because of their sickle cell, they can't work. There's, you know, barriers of not being able to work. And then you've got potential – you apply and say your disability, and sometimes that's not even taken on board either. So, you've just got these barriers in place that just make living day to day so exhausting, so tiring, and basically you're fighting those barriers at every – you think you've passed one, you've come onto another.  And I guess also the research side, which – it's funny because I would say, when it comes to research, it's fantastic, yes, that organisations like yourself are looking into it, but actually sometimes it's not even – you can't make the change where it's going to matter immediately. It's literally the frontline, you go into hospital and A&E, that's your first barrier is trying to just get some pain relief or get any treatment. You're sitting there for four hours. Four hours in pain for a person with sickle cell, that can really, you know, make things worse. And that's the kind of – you kind of want the immediacy – like the frontline, those kind of things to change. And of course, yes, we do want more research and we do want people to take part, but it's those things where you might not necessarily have the power to make those changes immediately that people will be willing to take part in research like this, because you can't even just get the treatment that you need from the moment you step into a hospital.  That's kind of what I was thinking of as you are speaking about this. I'm like, you know, yes, this is great, but we just need sometimes just going into hospital to make it easier. Like what Oleander said, it's unfortunate that the persons being asked about their PCA, if they're in pain – well, what do you think? Like that's just the basic [laughter], you know. It's kind of like, how can you ask that question and you're a healthcare professional being on the frontline? And that's the worst. It's the frontline staff sometimes which actually need the education. So, some of this research, it needs to go to education in these staff actually, you know. That's maybe an area that needs to be sorted.   Marie: For me, I completely have a whole new deeper appreciation for almost seeing people as the whole, how you work with the person. And it's never been clearer to me - as I say, you know, in ten-plus years' experience of doing this kind of work, it has never been clearer to me how important that is than now I work on sickle cell and how important that is. And I think that actually you've touched on a really important point there, which is that, you know, I know for sure that there's incredible work going on through NHS England, through the inequalities workstream and in response to the No One's Listening Report. There seems to be, you know, a huge increase in sort of focused action being taken to address a lot of these challenges that are being brought up in our conversation now.   But actually, what you said, Natasha, did kind of really hit the nail on the head a little bit for me, which is that actually we kind of still look at this as kind of separate organisations, like, “Well, this is my bit and that's your bit, so you stay over there.” And I think that something that we're trying to start working towards through the Sickle Cell Society is actually how do we bring together a better sort of alliance of work and of people who are across research and healthcare, because these things feed into each other, right? So, how can we do better to sort of show that we are all aligned, that there isn't just this one person or one group over here looking just at this little bit and then there's a completely separate group, that we are all actually united in our, you know, intentions here to really improve the lives of people that are living with this condition. But of course, there's just so much work to do, isn't there? I think that's another overwhelming thing, that everything needs to be better when it comes to sickle cell.  Oleander: The thing I wanted to just add to this whole talk about what researchers can do in terms of supporting advocates, etc. Two things, understand that there is an issue for trust from our communities, because we've been burnt. And the second one is, we need transparency. So, be real when you talk to people about the information you're gathering, what you're going to do with it, how it's going to impact the research, timetable of whatever's happening, all of those things which will help people to gain more trust.  Natasha: Yeah, Oleander, that's so – yeah, I think definitely, that's been echoed throughout this whole project, hasn't it? It's always about gaining that trust, because it is a case of, is this another where we're going to have support and we're going to be let down, or, you know, lied to, whatever you're going to find out. And trust is a huge part of that, definitely, yeah. I think, yeah, definitely. Thanks Oleander for saying that, it is.   Marie: Yeah, thank you all. So again just to say that I'm always blown away by just how generous you all are actually with what you say and with what you share, and with the messages that you're ultimately trying to get across. And it's very humbling, you know, to be able to work with you all, ‘cos you all are so incredibly passionate and driven, despite so many challenges, and it is nothing but inspiring. So, I can see absolutely why, you know, people living with sickle cell, for example, are called warriors, because you need to have that sort of fighting spirit to just keep going, and I have nothing but, you know, boundless like respect and admiration for people who are able to do that and contribute to the community in the ways that you all do.   And I just think that again, you know, so talking now back to this idea of how research is set up, you know, I myself am part of an initiative that's been, you know, initiated and only kind of guaranteed funding for this kind of iteration, for three years. It's very difficult to sort of initiate and establish really good long-term relationships, and have like a longer term strategic sort of way in which you're bringing in people and taking that long sort of like approach to building relationships, but it's something that I've tried to be really mindful of actually, and to address a lot of the things that you just mentioned.  You've heard us refer to other members of our patient voice group. Let's now take a moment to hear from them.  Samuel: Hello, my name is Samuel and I'm from Leicester. I have had the great privilege of working with some amazing people in Genomics England over the last few months, to hopefully one day be a part of something that takes down this condition that I struggle with known as sickle cell. Since John James of the Sickle Cell Society introduced me to Marie from Genomics England, there has been a door opened where the voice of a person dealing with the condition matters and holds weight, to help know what is required to further improve matters for people dealing with said condition. Hopefully, after reading the blog and hearing this podcast, you will know more about the work we've been doing, and feel as encouraged as we do. We don't just want to stop here. There's a long way to go, and we need all the help we can get to reach our goal together.  Hazel: Hi everyone, I'm Hazel. I hope you enjoyed the podcast. Now we're not done just yet. Keep your eyes out for our sickle cell and Genomics England patient takeover blog, where Natasha, Sam and I take you through what we've been up to and the future of genomics.   Zainab: Hi, my name's Zainab and I co-chair the Genomics England diverse data advisory board. I also have the pleasure of being part of the patient engagement group for this important piece of work. I've been a sickle cell advocate since before I even knew what advocacy was. As a child with sickle cell, I was exposed to different ways to help the community pretty early on, and have loved working with others to transform care for the better. Today, I hold a number of advocacy related leadership positions, including being a trustee of the Sickle Cell Society, chair for NHS England's patient advisory group for sickle cell health inequalities improvement, and a member of faculty for Medscape's committee on rare diseases. I also contribute to global sickle cell policy, practice and research.  I'm super excited about the work we do with Genomics England because I think they're a blueprint for what good patient centred work really looks like. My background is in health policies specifically related to research and innovation, so to see sickle cell being prioritised in this space is really special to me. We have an incredible opportunity to advance equity through research and innovation, especially related to genomics, and I myself am lucky to experience the transformative power of regenerative medicine. I'm excited for this group to continue to advocate for and enable better access for such incredible science.  Marie: We're very lucky to have such a wonderful group of people who are part of our patient voice group, and I hope you enjoyed meeting them. Just going back now to sort of what can be achieved, and if we, say, come back together in a year's time, knowing the kinds of things that we've just talked about briefly that we maybe want to look at – we've mentioned things like doing more family sessions, looking at how we can engage young men in particular, doing what is needed to kind of give that really strong message about how you support people to be part of these kind of patient advocacy roles. But what would you really like to see that we've achieved together by say this time next year? I'll come to you first, Jayson, this time.  Jayson: Thank you very much. Going straight to the point, I would like us to have more one to one with the patients and family in terms of – mainly I think to move towards the male, because, you know, I'm a living experience of some of the things that's happening, and put the awareness out there, and let them know that – not to scare them, but to give them adequate information to be able to arm and tool themselves for a better life for themselves, a better respite for themselves, and a better understanding of the situation. I know if sickle cell patients have enough time at work, at uni, at school, during their exams, they will achieve great results, and I would want that to be one of the forefronts of this campaign, to make sure that, you know, the male side – I do know a bit of the female side but I'll leave that to Oleander and Natasha, but the male side of what they should expect, and how to – if I could put this in (inaudible 0:33:59), I am making myself a role model for them, because I have leapt over barriers and over so many expectations, and if I could do it, with the science and the support we have now, they can double it, they can triple it, they can do more. My journey hasn't ended yet, but before it does, I want to tap into every organisation to hear more voice, to just give me five minutes to hear my voice.  Marie: Thank you so much, Jayson. I can't think of a better role model for young men who are dealing with this than you, so it's brilliant to see your dedication to that. Over to you, Oleander, what would you like to see – if we're here together in a year's time, looking back on what we've done over the last year and what's been achieved, what would you really like to see?  Oleander: I'd like to see sickle cell actually being taken seriously, that people don't make assumptions that, “Oh, it's just a small, you know, blood thing, it's nothing that deep, nothing that big,” whatever. Because the reality is, for a lot of indigenous people here, the majority ethnicity in this country, sickle cell is spreading because more people are mixing, more people have come over, refugees, economic migrants, etc, and mixing, and so they will find that actually it isn't just a tiny minority of people. We're told it's 17,000 people in the UK, but actually that number's going up. So, you know, it is a bit of a shame that it takes it to affect the ethnic majority in this country that anything would change, however this is the reality we live in. So for me, that's what I would like to see, that sickle cell is taken seriously, that we're not just stuck with one or two authorised drugs for people living with sickle cell, and actually one of them is not even a sickle cell specific drug.  So yeah, we want sickle cell to be taken seriously, and so that people can actually trust the process and trust the people who are genuinely trying to research issues to do with sickle cell, so that we can make the difference that we need to make for people's lives.  Marie: Thank you, Oleander. That just reminds me that, you know, hopefully – so, one of the projects that you are also involved in that we're doing is – and that's been already mentioned, the James Lind Alliance and the Sickle Cell Society partnership that we've got, the priority setting partnership. Hopefully, one of the things that's part of doing that is that we do create that sort of focused priority areas, and that's really strongly centred on the voices of people living with the condition, supporting people with the condition, whether they're parents, carers, healthcare professionals. So yeah, I completely agree, you know, really putting it on the map, taking it seriously, raising the understanding, raising it as a priority, I think that would be great to see in a year's time for sure. So of course, last but not least, over to you, Natasha.  Natasha: Well, Oleander has literally taken the words out of my mouth. That is exactly what I would want to see in the next year, and to me, it can be done. There should be no reason why it can't be, with all the technology, with all the advancements that's happening. There is no reason why sickle cell should not be leaps and bounds with the information, with the project, of getting this information from sickle cell patients. It should come to a point where actually no one has to suffer from sickle cell because, you know, the – what's it called, the medication, that one that's recently come out, that's way overdue. I can't even believe it's taken this long to just come up with that one, you know. The stem cell treatments and what they give as an alternative, it's not good enough basically. And, you know, we had this new one come out – I say new one, but this hydroxycarbamide, it's like that wasn't even for us. It was all by mistake that, “Oh actually, this might help sickle cell, let's see.” And that's what's the afterthought, and we shouldn't be an afterthought. It should be a priority.   And yeah, having that priority setting that we're doing with the James Lind Alliance – it's funny, ‘cos I remember, we had a call in our patient voice – I think he mentioned – I think it was something about maybe the questionnaire that we were going to give people, or – I can't remember the particular thing which I said to you, you're having trouble – you know, we're underrepresented, there's no data on us for a reason, and you had a template, and it's like this template's not going to work, because you have to approach it differently. Like you have to literally rip it up and start from the very beginning, because what you've tried to do in the past hasn't worked, or, you know, the majority of people, especially in the European world, it works for them, great, but you're coming to an underrepresented community and you're thinking, “Oh actually, we can just use that thumbprint and put it on this.” No, you've got to start again.  And I think it brings the importance of actually taking part in things like this, is that without actually knowing this, you would have thought, “Oh actually, people just aren't interested, you know. Patients don't want to know. They don't want to give any information over to us.” But it's like, well no, it's not that at all, it's just that you need to approach us differently. You need to, you know, understand what actually we're going through before you can then try and fix anything or provide information, or get, you know, medication advancements. Like these things need to be done and the groundwork first, and not thinking, “Oh okay, we can just put a little plaster and that'll heal that.”  So for me, definitely, more options when it comes to treatment. And, you know, that we're not the minority when it comes to data. Because especially with sickle cell, it affects different people in so many different ways, and they're just trying to understand, “Oh, why does it affect this person this way but it hasn't done it in this person?” And it's just like, great, you're asking these questions, but now let's move it forwards. Like let's not keep talking and let's start the action. And that's probably one of the other things is, I want to see the action. It's the action now. You know, of course, if you want us to talk, we'll talk, you know. We won't stop, and we can keep going. But ultimately let's actually have some movement. Let's have an action that you're – I say you as in you as an organisation, but wider, everybody that's part of the process comes and says, “Look, this is what we've been able to achieve.” And, you know, then you know you have been listened to. A bit like Jayson said, you know, still not listening. Actually, now you can say, “Yes, we've heard and now this is what's come from it.” So yeah, that's probably I think for me the biggest utopia is that actually sickle cell just won't exist. It's done. They've been able to sort it out [laughter], it's no longer an issue at all. But yeah, we won't get to that next year, but, you know, hopefully eventually down the line there is that cure or change that they can do.  Marie: I think for me, it kind of just brings me back to this point that there needs to be a united front in terms of like dealing and addressing with this. And also importantly, it needs to come from the community itself in terms of setting the priorities of what is done now, what is immediately needed to be done now, what can be looked at maybe a little bit later down the line, as there's maybe a bit more information, a bit more understanding, a bit more knowledge to kind of maybe base some things on. But yeah, every time I hear, you know, people speak about all the various challenges that, you know, of course, come from their own lived experience and having to see how this affects their community, and yes, there are steps being made in the right direction, but I think we all probably agree that we could all probably be doing more to just improve the way we're uniting this work, and we're doing it in a way that is really coming from the community themselves and saying, “We want this to happen now and in this way, and this is what we want you to look at addressing.”  We'll wrap up there. Thank you to my co-host Natasha Gordon-Douglas, and guests Oleander Agbetu and Jayson Kupoluyi for joining me today as we discussed engaging people with lived experience of sickle cell in research and advocacy. If you'd like to hear more about this, please subscribe to Behind the Genes on your favourite podcast app. Thank you for listening. I've been your host, Marie Nugent. This podcast was edited by Bill Griffin at Ventoux Digital, and produced by Naimah Callachand. 

Join Journal Club Download my free guide to Internal Bleaching PDF Follow @dental_digest_podcast Instagram Follow @dr.melissa_seibert on Instagram Connect with Melissa on Linkedin  DOT - Use the Code DENTALDIGEST for 10% off   Qualified at the Royal London Hospital in 1995; achieving a number of awards including The Constance Klein Memorial, The Stafford Millar, and The Malcolm Jenkins Scholarships, The American Association of Endodontics Prize and the Overall Award for Clinical Dentistry. After spending 3 years in oral surgery residency in London and a further year practicing restorative dentistry in London's Harley Street Medical District, he relocated to Cornwall in the extreme southwest of England. Jason practices at Revitalise, Cornwall, UK where his main focus is microscope enhanced adhesive dentistry. His specific interest is direct composite resin artistry and minimally invasive all ceramic restorations and he has presented to dentists locally, nationally and internationally (USA, Canada, Australia, New Zealand, South East Asia and Europe) on this topic. He has given hands on programs in the UK, Europe, Asia, and North America on behalf of GC, Ivoclar, Kerr, Kulzer, Optident, Micerium, Carl Zeiss, Zumax, Global, Velopex and Triodent. He is a European “Key Opinion Leader” for Kulzer and is a member of the European Prosthodontic Advisory Board for GC Europe. Jason is Resident Faculty at The Centre for Esthetic Excellence, Chicago, USA. He is an Accredited International Trainer for Carl Zeiss Dental Academy. Jason is the only European Resident Faculty at Spear Education AZ USA, where he is an instructor in The Composite Program. Jason has achieved Diplomat Status in Restorative Dentistry from the Royal College of Surgeons (England). He is on the Editorial Board of The Russian Journal of Esthetic Dentistry and has published numerous peer-reviewed articles on adhesive and aesthetic dentistry in both the UK and abroad. He is joint author of “Vertical Margin Finish Lines In Fixed Prosthodontics”   

Professor Robert Thomas is well know for his pioneering work trialling natural agents for use in cancer care and also for his books, including the recent 'How to Live'. Alongside his work as clinical oncologist, he has now been appointed to lead the oncology side of services at the Royal London Hospital for Integrative Medicine, for which he has some ambitious plans.

Born into a large family, and destined for a career at his fathers greengrocers, Roach decided to join the Army aged 17 and joined an infantry unit. First deployed to Gibraltar, where he first encountered members of the Special Forces, training alongside them for a hijacking response team role. Roach was unsuccessful in his attempts to pass SAS Selection, and went on to attempt 23 SAS (Reserve) Selection, before moving into the Ambulance Service. Roach was one of the first Paramedics on the streets of London, and became part of the HEMS team at Royal London Hospital. Eventually transferring to South Africa, Roach developed his trauma experience, and then lectured on his return to the UK. Roach went onto the Close Protection Circuit, and worked with clients like Sir Elton John, Saudi Royals & Russian Oligarchs. Keen on bushcraft and survival, Roach went on to launch a successful YouTube channel, amassing over 3 million views and progressing onto National Geographic's Doomsday Preppers programme. Follow This Podcast To Be Notified Of New Episodes, Visit Our Social Media Platforms & YouTube Channel For More Bonus Content, And Listen Live To Our Radio Station: Listen Live: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.forceradio.live/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Visit Our YouTube Channel: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/@forceradiohq

Dr Ghassan Abu-Sittah is no stranger to conflict zones, having  spent decades volunteering for medical charities in Palestine, Lebanon, Yemen, Syria, and Iraq. But the plastic and reconstructive surgeon says his latest experience in Gaza has no parallel. The scale of the current suffering in Gaza, “the intensity, the ferocity, the viciousness, and the deliberate targeting of the hospitals”, he says, was like "a tsunami”.Dr Abu-Sittah travelled to Gaza days after Israel began its bombardment in response to the October 7 attack by Hamas. He remained in the besieged enclave for 43 days, working mainly in northern Gaza as a volunteer for Médecins Sans Frontières (MSF).He was at Al-Ahli Hospital during the massacre on October 17, 2023, and was among the physicians who spoke to news media, surrounded by blood-stained bodies, in the attack's immediate aftermath. He later gave evidence to the International Court of Justice (ICJ) at The Hague about what he saw.In this moving interview with Maysa Jalbout, Dr Abu-Sittah shares his experiences of working in Gaza and what it was like knowing his wife and children were watching him caught up in the attacks in real time on social media.Since returning home to the UK, he has announced plans to set up The Ghassan Abu Sittah Children's Fund to pay for injured Palestinians to receive medical and rehabilitation treatment in Lebanon.Children have borne the brunt of this latest chapter of conflict in Palestine. Before October 7, there were nearly 200 war-related amputations among young people in Gaza as well as some 2,000 adults living with amputations from earlier conflicts. Dr Abu Sittah says there could now be as many as 5,000 child amputees, with many losing limbs due to an inability to treat what would ordinarily be very salvageable injuries.Children with amputations need new prosthetics every six to eight months as they grow and could require as many as 12 surgeries before they reach adulthood, he explained. In addition to the physical impact of their injuries, their mental health needs are also “life altering”. Dr Abu-Sittah was born in Kuwait after his parents were forced from their homes in Palestine in 1948 and became refugees in Gaza. He studied medicine at the University of Glasgow and after completing his Specialist Registrar training in London, he went on to do fellowships  in Paediatric Craniofacial Surgery and  Cleft Surgery at Great Ormond Street Hospital for Sick Kids and then a fellowship in Trauma Reconstruction at the Royal London Hospital. In 2010 he was awarded Fellowship of the Royal College of Surgeons (Plastic Surgery).  Dr Abu-Sittah has served as an associate professor and head of the Division of Plastic and Reconstructive Aesthetic Surgery at the American University of Beirut (AUB) Medical Center,  in 2015, became a founding director of the Conflict Medicine Program at AUB's Global Health Institute, and in March was named Rector of the University of Glasgow.The Impact Room is brought to you by Philanthropy Age and Maysa Jalbout. Find us on social media @PhilanthropyAge

Dr. Manoj Ramachandran from Royal London Hospital and Barts Health joins Nick Fletcher for a broad-ranging conversation about his multifaceted career, including multiple entrepreneurial successes, authoring numerous books, building a practice, leading a department, and more. Dr. Ramachandran also offers illuminating insights into how artificial intelligence can advance our field. Produced by Nick Fletcher and Carter Clement. Music by Christian Bjoerklund.

In this episode of the Backtable Podcast, guest host Dr. Paul Bhogal, a consultant interventional neuroradiologist at Royal London Hospital in the UK, and guests Dr. Piotr Walczak and Dr. Prakash Ambady discuss the potential of intra-arterial treatments combined with blood brain barrier (BBB) manipulation in treating various neurological conditions and tumors. The trio of doctors discuss methods such as the use of hyperosmolar mannitol and focused ultrasound to breach the BBB and deliver drugs directly to the brain tissue. Dr. Walczak and Dr. Ambady also highlight their individual research areas, including therapies involving cell delivery and engineered cells. The conversation also covers potential risks and new perspectives in comparison to current techniques such as whole-brain radiation. --- CHECK OUT OUR SPONSOR RADPAD® Radiation Protection https://www.radpad.com/ --- SHOW NOTES 00:00 - Introduction 05:44 - Challenges of Treating Glioblastoma Multiforme 12:52 - Understanding the Blood Brain Barrier 18:30 - Strategies to Negate the Blood Brain Barrier 20:52 - Blood Brain Barrier Disruption Using Intra-Arterial Mannitol 26:35 - Infusion Rates and Magnetic Resonance Guidance 33:47 - Role of Radiolabel Studies in Drug Delivery 36:31 - Future of Therapeutic Agents Design 47:54 - Potential of Focused Ultrasound in Drug Delivery 56:10 - Exploring the Use of Cells in Drug Delivery 58:44 - Future of Intra-Arterial Interventions --- RESOURCES Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma: https://pubmed.ncbi.nlm.nih.gov/15758009/ Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial: https://pubmed.ncbi.nlm.nih.gov/19269895/ REMOVAL OF RIGHT CEREBRAL HEMISPHERE FOR CERTAIN TUMORS WITH HEMIPLEGIA - PRELIMINARY REPORT: https://jamanetwork.com/journals/jama/article-abstract/254927 Real-Time MRI Guidance for Reproducible Hyperosmolar Opening of the Blood-Brain Barrier in Mice: https://www.researchgate.net/publication/328537972_Real-Time_MRI_Guidance_for_Reproducible_Hyperosmolar_Opening_of_the_Blood-Brain_Barrier_in_Mice Dr. Piotr Walczak ResearchGate Profile: https://www.researchgate.net/profile/Piotr-Walczak-6 Dr. Prakash Ambday ResearchGate Profile: https://www.researchgate.net/profile/Prakash-Ambady Maculopathy Associated With Osmotic Blood- Brain Barrier Disruption and Chemotherapy in Patients With Primary CNS Lymphoma: https://pubmed.ncbi.nlm.nih.gov/32484895/ PET imaging of intra-arterial 89 Zr bevacizumab in mice with and without osmotic opening of the blood-brain barrier: distinct advantage of intra-arterial delivery: 10.2967/jnumed.118.218792 Safety of intra-arterial chemotherapy with or without osmotic blood–brain barrier disruption for the treatment of patients with brain tumors: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307096/ Delivery of chemotherapeutics across the blood-brain barrier: challenges and advances: https://pubmed.ncbi.nlm.nih.gov/25307218/

This special episode of RealTalk MS is sponsored by EMD Serono and is only intended for a U.S. audience. EMD Serono is the healthcare business of Merck, KGaA, Darmstadt, Germany, in the United States and Canada. In this special episode of RealTalk MS, we're exploring what the invisible symptoms of MS are, and how to best empower people living with MS to talk about them with their healthcare team. Professor Klaus Schmierer is a Professor of Neurology at the Blizard Institute, Queen Mary's Univerrsity of London and a Consultant Neurologist at the Royal London Hospital, which is part of Barts Health NHS Trust in the U.K. Professor Schmierer has a keen interest in MS and focuses his research on the underlying mechanisms of the disease and how to improve diagnosis with imaging tools, such as MRI. Jane Shanahan is a patient advocate who was diagnosed with MS in 2016. Jane lives with her husband and two children. She has developed an interest in better understanding MS, as well as educating her family, friends, colleagues, and others about the disease. Both Professor Schmierer and Jane are active members of the MS in the 21st Century initiative. MS21 is a Merck KGaA, Darmstadt, Germany, initiative involving healthcare professionals and patient advocates. To learn more about MS in the 21st Century, please visit www.msinthe21stcentury.com.

"It's like having a backstage pass to the world." That's how Dr. Stephen Fabes describes his epic adventure exploring all six inhabited continents on a bicycle. Over the course of 6+ years, he cycled across 75 countries and 53,000 miles, discovering how human stories shape our conceptions of health and illness. Currently an acute medicine specialist at the Royal London Hospital, Dr. Fabes is also the author of the 2020 memoir Signs of Life: A Doctor's Journey to the Ends of the Earth. His writings have also appeared in The Guardian, The Telegraph, CNN, and the BBC. In this episode, he joins us to share thrilling, thought-provoking, and amusing moments from his journey, what his travels through refugee camps and war-torn hospital wards have taught him about health care at the margins, and stories of everyday kindness that underscore our common humanity.In this episode, we'll discuss: 2:07 - Why Dr. Fabes decided to become a doctor 3:50 - The roots of Dr. Fabes' sense of adventure13:16 - How medical training differs in the UK and the US14:34 - Dr. Fabes' planning process for his 6+ year international bicycle journey16:20 - A recap of the path that Dr. Fabes took on his 53,000 mile21:15 - The most challenging aspects of Dr. Fabes'  journey and how they gave him the urge to visit medical projects on his travels23:11 - How Dr. Fabes grappled with the moments when his health or life was in jeopardy27:28 - Dr. Fabes' takeaways from observing such a wide variety of international medical practices32:38 - The challenges that arose as Dr. Fabes' transitioned back to regular life after his trip35:27 - How Dr. Fabes' experiences have shaped how he now approaches medicine 36:42 - The importance of keeping an open mind in order to best meet your patients where they areTo learn more about Dr. Fabes' book Signs of Life: A Doctor's Journey to the Ends of the Earth and his work, visit https://stephenfabes.com/Follow Dr. Fabes on Twitter/X at https://twitter.com/DrStephenFabes.Visit our website www.TheDoctorsArt.com where you can find transcripts of all episodes.If you enjoyed this episode, please subscribe, rate, and review our show, available for free on Spotify, Apple Podcasts, or wherever you get your podcasts. If you know of a doctor, patient, or anyone working in health care who would love to explore meaning in medicine with us on the show, feel free to leave a suggestion in the comments or send an email to info@thedoctorsart.com.Copyright The Doctor's Art Podcast 2023

Dr. Amy Ross Russell (1) is joined by Dr. Desmond Kidd (2) to discuss the paper “Neurological involvement by Behçet's syndrome: clinical features, diagnosis, treatment and outcome”. Read this latest Editor's Choice paper on the Practical Neurology website (https://pn.bmj.com/content/23/5/386) and the October print issue of the journal. The paper is also discussed by the Practical Neurology editors, Dr. Phil Smith and Dr. Geraint Fuller, in their latest podcast: https://pnbmj.podbean.com/e/editors-highlights-of-the-october-2023-issue/ (1) Neurology, University Hospital Southampton NHS Foundation Trust, UK (2) Behçet's Syndrome Centre of Excellence, The Royal London Hospital, London, UK (https://www.behcets.nhs.uk) Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole. Thank you for listening.

Mike talks with Tessa Davis about the art of presenting data in an engaging way from the stage and online, that time her work showed up on late night shows, and Tessa shares a story about her most prestigious audience member.Tessa Davis (@tessardavis) is a Pediatric Emergency Medicine consultant at the Royal London Hospital, a Senior Lecturer at Queen Mary University of London, and a co-founder of the medical education collaboration Don't Forget the Bubbles. She also advises, coaches and ghostwrites for executives and medical personnel. She is found at tessardavis.com.Mike Pacchione (@mpacc) is a public speaker, a speaking and storytelling coach and a corporate communications specialist. He can be booked for individual, group and corporate coaching at BestSpeech.co.

Britain is exhausted.Sleep deprivation is on the rise across the UK and it's costing the country billions.And as the cost-of-living crisis doesn't seem to be going anywhere, more and more are struggling to get a good night's rest.So, what's keeping us awake? And why is the government not doing much about it?ITV News Correspondent Rachel Townsend and Dr Hugh Selsick, who leads an Insomnia Clinic at The Royal London Hospital for Integrated Medicine, tell Tom Bradby What You Need to Know…To hear more on this, tune in to ITV's Tonight on Thursday 24th August at 20:30pm.

Dive into a deeper understanding of the role of inflammation in causing injury to the brain and spinal cord in multiple sclerosis. It's a journey marked by ups and downs, where the adaptive immune system composed of lymphocytes (T and B cells) attack myelin and the innate immune system clears damaged myelin. An immune cell called microglia can create smoldering inflammation in MS that poses a threat of progressive disability. Explore the arsenal of MS treatment strategies developed over the past 3 decades to either alter or suppress the immune system to reduce inflammation. Triumphs and limitations of our current MS therapies shared. Antioxidant research, diet and new therapeutics tackling smoldering inflammation bring newfound hope. Barry Singer MD, Director of The MS Center for Innovations in Care, interviews: Klaus Schemierer MB BS, PhD, FRCP, Professor of Neurology at the Blizard Institute, Queen Mary University of London, and Consultant Neurologist at The Royal London Hospital, Barts Health NHS Trust. Michael Kornberg MD, PhD, Assistant Professor of Neurology at John Hopkins.

Jeremy Joseph, a consultant ophthalmic surgeon began his medical school training in 1977. He then conducted his ophthalmology training at the Royal London Hospital. He was appointed as a consultant in 1994. He then continued his post at the Central Middlesex Hospital. Mr. Joseph retired from practice in 2018 with the intention of continuing to work abroad for charities. On this episode Jeremy speaks to Pavandeep Singh to discuss the world of extreme medicine and ophthalmology. Mr. Joseph, a consultant ophthalmic surgeon with extensive experience in cataract surgery and ophthalmology across the globe, trained Singh in manual small incision cataract surgery during a trip to Bolivia. The speakers delve into the challenges of surgery in low-resource areas and adapting to different environments, including language barriers and inadequately skilled staff. They also highlight the importance of encouraging local surgeons and not imposing methods used in one's home country. Jeremy emphasise the life-changing benefits of going on expeditions as a way to give back and make a difference. The episode also features the Jeremy's personal experiences, including his first expedition abroad to Brazil and his resilient mindset.

In this conversation we will examine the prevalence, types, and challenges of pelvic trauma. We will also look at some of the pre-hospital and Emergency Department management of pelvic trauma and why it can be such a critical injury to treat. To do this I am speaking with Ash Vasireddy. Ash is a fellowship-trained Orthopaedic Trauma Surgeon specialising in the management of complex upper limb, lower limb, pelvic and acetabular fractures. He works at King's College Hospital (Major Trauma Centre) in London. He completed further specialist Orthopaedic Trauma training at The Royal London Hospital, as well as Orthopaedic Trauma Fellowships at Queen's Medical Centre in Nottingham and King's College Hospital in London. In addition, Ash has also completed travelling fellowship visits to multiple major trauma centres in America, including the Shock Trauma Centre in Baltimore and Harborview Medical Centre in Seattle. Ash also has extensive experience in Emergency Medicine, Intensive Care and Anaesthesia. He is also a Consultant at Essex and Herts Air Ambulance (EHAAT) and research lead for EHAAT. In the conversation we examine: Why a pelvic fracture is so critical The pre-hospital prevalence What are the main types / classifications The spectrum of injury – pain to life threatening blood loss Pre-hospital assessment of the pelvis Some of the common issues seen as an Orthopaedic Trauma Surgeon IR vs OR Possibilities of REBOA within the Air Ambulance Service Lessons learnt from practice (pre-hospital and in-hospital) Seminal cases Final thoughts & take-home messages. In the conversation Ash mentions the two common types of Pelvic classification, these are: TILE: https://litfl.com/classification-of-pelvic-fractures/ Young and Burgess classification of pelvic ring fractures: https://radiopaedia.org/articles/young-and-burgess-classification-of-pelvic-ring-fractures?lang=gb My thanks to Ash for an insightful and engaging interview.

Support the Delingpod's existence by joining James’ Locals: https://jamesdelingpole.locals.com/ Dr Michael Mew qualified in the 1993 as a dentist at the Royal London Hospital. After several years in general practice, community dentistry and facial surgery, he entered the renowned Orthodontic programme at Aarhus University in Denmark, qualifying as a specialist dentist in 2004. He is […]

Support the Delingpod's existence by joining James' Locals: https://jamesdelingpole.locals.com/   Dr Michael Mew qualified in the 1993 as a dentist at the Royal London Hospital. After several years in general practice, community dentistry and facial surgery, he entered the renowned Orthodontic programme at Aarhus University in Denmark, qualifying as a specialist dentist in 2004. He is particularly interested in the cause of crooked teeth and the Aetiology of Malocclusion, he feels that when the profession understands so little, it is best to start at the bottom and work up.   Freedom isn't free - James needs your support to continue creating The Delingpod. There are many ways you can show your support to James: Join the James Delingpole Community as a paid supporter at: jamesdelingpole.locals.com Support James monthly at: subscribestar.com/jamesdelingpole Support James' Writing at: substack.com/jamesdelingpole www.delingpoleworld.com Buy James a Coffee at: buymeacoffee.com/jamesdelingpole   Find full episodes of The Delingpod for free (and leave a 5-star rating) on: Apple Podcasts: https://podcasts.apple.com/gb/podcast/the-delingpod-the-james-delingpole-podcast/id1449753062 Spotify: https://open.spotify.com/show/7bdfnyRzzeQsAZQ6OT9e7G?si=a21dc71c7a144f48 Podbean: delingpole.podbean.com Odysee: https://odysee.com/@JamesDelingpoleChannel:0 Rumble: https://rumble.com/user/JamesDelingpole BitChute: https://www.bitchute.com/channel/Zxu5yMwNWTbs/ YouTube: https://www.youtube.com/c/TheJamesDelingpoleChannel   Follow James on Social Media: Twitter: twitter.com/jamesdelingpole Instagram: instagram.com/delingpodclips GETTR: gettr.com/jamesdelingpole Telegram: https://t.me/+dAx_7JX7WQlwYzVk  

In this session we will examine the latest research to emerge from Zane Perkins and Mike Christian around Resuscitative Thoracotomy (RT). The research has been led by Zane and Mike examined over 600 retrospective thoracotomy cases from the LAA database spanning 20 years, looking at the survivors, the pathology (exsanguination versus tamponade), the pre-arrest rhythms, the morbidity and mortality, the time of intervention versus outcome as well as other markers. I wanted to explore the results of this research and the potential implications on practice. Zane Perkins is a consultant Trauma and General Surgeon at the Royal London Hospital, a consultant Physician for London's Air Ambulance, and an Honorary Senior Lecturer at the Centre for Trauma Sciences, Queen Mary's University London. Current thinking on Thoracotomy practice Examine the research in more detail from primary & secondary outcomes Survival rates - Who are the current survivors? What are the main domains of pathology Exsanguination: Results of outcome and pre-arrest rhythms What it shows around intervention and decisions around exsanguination Tamponade: results of outcome and pre-arrest rhythms What it shows around intervention and decisions around tamponade Differentiated decision making and prospective changes to SOP Final thoughts and take-home messages. The study has yet to be published but we will publish the results as they are published. My thanks to Zane for an engaging and insightful interview.

As patients live longer their needs are becoming more acute during surgery; this piece asks how we can adapt practice to meet the new challenges this brings. These talks take a long view across the perioperative continuum with a focus upon cognitive impairment and other vulnerable brain patients. Presented by Laura MacDarby, Consultant Anaesthetist in The Royal London Hospital, a referral centre for Major Trauma and Stroke in the Whitechapel area of London and Roisin Coary, SpR in Geriatric and General Internal Medicine, with a specialist interest in Peri-operative Medicine, currently based in Dublin, Ireland.

Dr Hatem Algraffee has gone from being a confessed lazy student to one of the busiest clinicians in the profession.   After completing two master's degrees as one of the UK's first periodontal specialists, Hatem took on 13 jobs simultaneously—and then things got even busier!   He discusses some of the niche and specialist skills needed to get ahead in perio, reveals why you don't need to specialise in 2022, and predicts a bright holistic future for the discipline.   In This Episode 01.32 - Being busy 02.44 - Backstory and dental school 10.47 - Why periodontics? 22.33 - Specialist and niche skills 39.45 - New periodontal grading 44.30 - Periodontics and physical health 50.57 - Grafting and predictability 54.53 - Regulation and the future of perio 01.00.50 - Blackbox thinking 01.06.08 - Practice, training and family life 01.14.44 - If I had $1BN 01.19.29 - Fantasy dinner party 01.22.22 - Last days and legacy About Hatem Algraffee Hatem Algraffee graduated from the Royal London Hospital in 1996 and went on to specialist training at Guy's Hospital and King's College, where he completed two master's degrees.   In 2004, Hatem founded the Perio Academy centre for periodontal training. He now divides his time between specialist practice and training. 

In this episode, Shafi Ahmed, Chief Medical Officer, and surgeon at the Royal London Hospital for the NHS, presents what has been the arrival of the metaverse to the healthcare industry.  Thanks to 5G and Virtual Reality technology, there are many possibilities and opportunities for healthcare that are starting to pop up. We might be looking at the dawn of a brand new hospital experience within the metaverse. We're now entering a Web 3.0 era, converging the digital and physical worlds seamlessly.  Blockchain technology, NFTs, machine learning, and AI will bring forward new ways to share data securely, opening a lot of doors for many industries. Shafi explains why more connectivity is needed to allow something closer to the Internet of Things in the hospital and how the metaverse presents an interesting alternative.  It all starts by creating another version of yourself, to create an avatar for you to enter the space with ML, AI, voice technology, and photogrammetry. Shafi believes this will enable virtual education to be more immersive and global than ever before, especially for healthcare training. He presents Aimedis's healthcare city in the metaverse as a place where doctors, hospitals, and caregivers can get in touch with patients worldwide and offer them services and support. The plan is for it to be as easy as turning on a smartphone and entering your metaverse property, where you can connect to a healthcare professional in another corner of the world. Shafi discusses how data will be key in defining what that metaverse looks like, as it allows users to share their data better and even monetize it at Aimedis's Data Exchange Marketplace.  Listen to this episode to learn from professor Shafi Ahmad how the metaverse and the healthcare industry are inevitably meshing together in many different fields for the better!

Click here for Spear Live December 2-3 2022. Podcast Website Follow @dental_digest_podcast Instagram Follow @dr.melissa_seibert on Instagram Connect with Melissa on Linkedin Dental Digest Podcast Facebook Qualified at the Royal London Hospital in 1995; achieving a number of awards including The Constance Klein Memorial, The Stafford Millar, and The Malcolm Jenkins Scholarships, The American Association of Endodontics Prize and the Overall Award for Clinical Dentistry. After spending 3 years in oral surgery residency in London and a further year practicing restorative dentistry in London's Harley Street Medical District, he relocated to Cornwall in the extreme southwest of England. Jason practices at Pure Dental Health and Wellbeing, Cornwall, UK where his main focus is microscope enhanced adhesive dentistry. His specific interest is direct composite resin artistry and minimally invasive all ceramic restorations.

From humble East End beginnings, Sarah Elliston followed her dental vocation with a nursing, fresh from high school, before moving onwards with a place at Royal London Hospital's competitive therapy training.   She recounts how her finals and first job were almost interrupted by a life-threatening illness, discusses hierarchies in the profession and answers the question on everyone's lips: Just what is guided biofilm therapy?       Sarah lets us know why she recently left therapy behind and offers a few tantalising clues about an exciting new road ahead.   In This Episode 01.53 - The state of play 06.33 - Skills and training 17.15 - Hierarchies in dentistry 24.05 - Backstory and career progression 37.08 - An unexpected diagnosis 47.53 - Guided biofilm therapy 52.19 - Blackbox thinking 57.56 - Bear 01.05.07 - Fantasy dinner party 01.07.08 - Last days and legacy About Sarah Elliston Sarah Elliston spent 11 years in dental nursing before gaining therapy qualifications with the Royal London Hospital in 2010. She has also worked as a clinical educator for Essex University. Sarah recently took a break from practice to develop a new range of dental products.

Click here for Spear Live December 2-3 2022. Podcast Website Follow @dental_digest_podcast Instagram Follow @dr.melissa_seibert on Instagram Connect with Melissa on Linkedin Dental Digest Podcast Facebook Qualified at the Royal London Hospital in 1995; achieving a number of awards including The Constance Klein Memorial, The Stafford Millar, and The Malcolm Jenkins Scholarships, The American Association of Endodontics Prize and the Overall Award for Clinical Dentistry. After spending 3 years in oral surgery residency in London and a further year practicing restorative dentistry in London's Harley Street Medical District, he relocated to Cornwall in the extreme southwest of England. Jason practices at Pure Dental Health and Wellbeing, Cornwall, UK where his main focus is microscope enhanced adhesive dentistry. His specific interest is direct composite resin artistry and minimally invasive all ceramic restorations.

Click here for Spear Live December 2-3 2022. Podcast Website Follow @dental_digest_podcast Instagram Follow @dr.melissa_seibert on Instagram Connect with Melissa on Linkedin Dental Digest Podcast Facebook Qualified at the Royal London Hospital in 1995; achieving a number of awards including The Constance Klein Memorial, The Stafford Millar, and The Malcolm Jenkins Scholarships, The American Association of Endodontics Prize and the Overall Award for Clinical Dentistry. After spending 3 years in oral surgery residency in London and a further year practicing restorative dentistry in London's Harley Street Medical District, he relocated to Cornwall in the extreme southwest of England. Jason practices at Pure Dental Health and Wellbeing, Cornwall, UK where his main focus is microscope enhanced adhesive dentistry. His specific interest is direct composite resin artistry and minimally invasive all ceramic restorations.

Your wellbeing - as busy health professionals - matters. At our annual conference in Liverpool this past June, we spoke with several members making a huge impact in their own hospitals and Trusts. This is the first of two episodes on wellbeing, and here we explore how to really understand the needs of the people you work with. First we hear with Dr Ash Patel at the Birmingham Children's Hospital on how sharing baked treats can be one way to build a culture of wellbeing. That's led to his popular baking columns in our membership magazine, Milestones, and the 'Great Paediatric Bake Off' series. And then Dr Susie Minson and Dr Benita Morrissey, both from the Royal London Hospital, explain how they've worked to create enduring resilience and happiness at work, bringing along the whole multidisciplinary team. Download transcript

This week, Prav sits down for a heart-to-heart with his friend, colleague and implant virtuoso, Riz Syed.   Riz describes how he almost fell out of love with dentistry before discovering implants and recounts his journey through dental school and beyond to eventually becoming a leader in the field.   He talks about what it takes to build up the confidence to carry out complex cases, reveals some of his darkest clinical moments and shares candid thoughts about his upbringing, fatherhood, family life and more.       Enjoy! In This Episode 03.50 - Backstory 10.04 - Deciding on dentistry 15.20 - Dental school 19.09 - Parenting, family and fatherhood 36.03 - The journey so far 45.23 - Skills building 50.31 - Blackbox thinking 01.05.46 - Complex treatment 01.23.16 - Last days and legacy About Riz Syed Dr riz Syed graduated in 1999 and spent time working in the oral maxillo-facial surgery department of Royal London Hospital.   He gained a master's degree in restorative dentistry from the University of California and has also completed training in advanced oral plastic surgery in Dallas, Texas.   He is a prolific surgeon, lecturer, and mentor who often teaches on behalf of Nobel Biocare.    Riz is a member of the Association of Dental Implantology, the International Congress of Oral Implantologists, a Fellow of the Royal Society of Medicine and the American Academy of Cosmetic Dentistry.

Date: July 22nd, 2022 Reference: Perry et al. Immobilisation of torus fractures of the wrist in children (FORCE): a randomised controlled equivalence trial in the UK. The Lancet 2022 Guest Skeptic: Dr. Tessa Davis is a Paediatric Emergency Consultant at the Royal London Hospital, Senior Lecturer at Queen Mary University of London, Co-founder of Don't Forget The […]

Join Dr. Jennifer Bell and Dr. Jason Smithson as they chat about esthetic direct and indirect restorative dentistry and the top 3 mistakes general dentists make when managing these cases.  To hear more interviews and watch our live shows visit:https://www.facebook.com/groups/dentistsintheknowAnd our YouTube channel hereDr. Jason Smithson: Qualified at the Royal London Hospital in 1995; achieving a number of awards including The Constance Klein Memorial, The Stafford Millar, and The Malcolm Jenkins Scholarships, The American Association of Endodontics Prize and the Overall Award for Clinical Dentistry. After spending 3 years in oral surgery residency in London and a further year practicing restorative dentistry in London's Harley Street Medical District, he relocated to Cornwall in the extreme southwest of England. Jason practices at Pure Dental Health and Wellbeing, Cornwall, UK where his main focus is microscope enhanced adhesive dentistry. His specific interest is direct composite resin artistry and minimally invasive all ceramic restorations.  

Looking for a bit of fantasy? How about some suspense?  Maybe you are looking for a mystery or a procedural police story?  Well, good news.  James R. Hannibal has them all!  His upcoming release, Elysium Tide, takes us to Hawaii with a doctor who doesn't know how to do this "vacation" thing and gets us embroiled in murder, some car thieves, and who knows what else!  Listen in to learn more! Note: links may be affiliate links that provide me with a small commission at no extra expense to you. Can You Imagine a Better Beach Read than Action & Mystery in Hawaii? Way back in Episode 15, I mentioned that Sarah Monzon (Not Susan... or should that be #NotSusan?) had recommended a lot of great books that I really enjoyed reading. One of those recommended books was James R. Hannibal's The Gryphon Heist. I handed it to Mom and was informed that I should read it.  Posthaste.  I have not yet read said book.  *insert shame-filled apologies here* ;) So, when I learned that James would be on the show, I raced to read the book and got it done in the--yeah. Total lie.  You saw it up there where I said I hadn't read the book yet.  But still, talking to someone I respect as much as I do Hannibal was a blast, and listening to him tell how he got so many of the little inspirations for parts of his upcoming release from his own family vacation to Hawaii, I knew Elysium Tide would be the book for me.  Oh, yeah.  Guess who ordered hers pronto?  From Baker Book House, no less. 40% off and free shipping.  Thought you'd want to know. ;) Seriously, just listening to James tell about the book's premise makes me want him to do a nice long series of books with these characters... and I haven't read a single word of the first book yet! And then I did something that changed the direction of the conversation. If you've ever listened to an episode of Because Fiction, you know that I always ask where readers can find more about the author. This time that question threw me for the proverbial loop.  Oh, yeah. He mentioned something in passing--Light Raiders--and whooooooooooooooah Nellie!  Guys! You have to check out all the amazingness of a role-playing game that focuses on understanding and infusing the Word into your heart! To learn more about the game you can go to the WEBSITE (and that's where you can learn more about James, too). To listen to the podcast episodes we talked about, you can go to Lorehaven and listen to a few different Fantastical Truth episodes. Elysium Tide by James R. Hannibal Dr. Peter Chesterfield is one of the Royal London Hospital's top neurosurgeons. He is also a workaholic, ordered by his boss to take a week off to attend a medical symposium at the luxurious Elysium Grand on the island of Maui. While there, Peter pulls a woman with a skull fracture from the water. Though he is able to revive her in the ambulance, she eventually dies in his arms, leaving him with only one clue to what happened to her: the word "honu." Increasingly obsessed with discovering the cause of his patient's death, Peter becomes entangled in an ongoing investigation of a brazen luxury auto theft. He also becomes a source of deep irritation to detective Lisa Kealoha, who has jurisdiction over the case. But when the two join forces, they begin to uncover a destructive plot that runs far deeper than either of them could have imagined. And if they're not careful, they're both going to end up dead. Award-winning author James R. Hannibal whisks you away to the deadly beauty of Hawaii for a story of greed, violence, and justice that will leave you breathless. Again, find out more about James. R. Hannibal on his WEBSITE. Like to listen on the go? You can find Because Fiction Podcast at: Apple  Castbox  Google Play Libsyn  RSS Spotify Stitcher Amazon and more!

On today's episode of the Mind Your Skin podcast, I am joined by Dr Alia Ahmed. Dr Alia is a Consultant Dermatologist who sees and treats adults and children for all skin conditions. Dr Ahmed specialises in the psychological effects of skin disease and the link between skin and stress. She now works in the NHS in Windsor at King Edward VIII Hospital and in London at the Royal London Hospital in Whitechapel. We dedicate this episode to discussing the link between mental health and acne. Anyone who's ever had a skin issue knows that it's more than skin deep - serious skin conditions and acne alike can have both mental and emotional effects. Acne can trigger symptoms of depression and anxiety and lead to poor emotional health. Dr Alia is working hard to try and destigmatize a condition that a vast majority of us suffer from at some stage in our life by improving our understanding of acne and the ways in which we can manage it.Find more information on Dr Alia Ahmed: Website: https://thepsychodermatologist.com/Instagram: @the_psychodermatologistDiscover your own skin wellness ritual at ernolaszlo.com. Type in code MINDYOURSKIN when checking out and you'll receive a complimentary welcome gift with your purchase!--Hosted by Poppy JamieProduced by Georgie RutherfordEdited by George Campen Hosted on Acast. See acast.com/privacy for more information.

It's a great episode this week. It's insomnia, it's breathing, it's fascinating.My first guest is Dr Hugh Selsick, a consultant in psychiatry and sleep medicine who runs a sleep clinic at the Royal London Hospital. Dr Hugh busts some common myths around treating insomnia and Domino snores the whole way through! I also speak to James Nestor who is an author and science journalist. He taught me a lot about the art of breathing and the science that backs it up.If you have questions or comments about any of the episodes so far, you can contact the podcast on Instagram, Facebook and Twitter, or you can email hello@wellbeinglabpodcast.com. I'd love to hear from you.Here are some useful links and resources: Dr Hugh recommends this free app for insomnia treatment, as well as these three books on the topic.Here's more info about James Nestor's best-selling book Breath.And here's all the info for MY new book Be Yourself and Happier. Hosted on Acast. See acast.com/privacy for more information.

Dr Isabelle Bond graduated as a medical doctor in Paris at the University of Pierre et Marie Curie, qualified in the specialty of Endocrinology, Metabolic diseases and Nutrition and further specialised in Functional Medicine. Over the past years Dr Isabelle Bond has integrated more Naturopathic Nutrition in her medical treatments. She studied at the CNM (College of Naturopathic Medicine) in London and holds the dipCNM. She is part of the Bioregulatory Medicine group (BRM) and holds its diploma in Bioregulatory Medicine. Dr Bond has passed her LFHom at the Royal London Hospital of Integrative Medicine. She is accredited in Functional Medicine for Clinical Practice (AFMCP) from the Institute for Functional Medicine (IFM) and has been practicing Functional Medicine for the past twelve years.

TopMedTalk's essential series on acute kidney injury continues, supported by the "Know AKI campaign" – a bioMérieux global campaign to raise awareness about AKI. For part one of the series follow this link: https://topmedtalk.libsyn.com/part-1-know-aki-and-say-no-to-acute-kidney-injury-for-patients-perioperative-renal-injury In this podcast you will discover how The Perioperative Quality Initiative (POQI) focuses upon renal injury. How do we identify patients early? How do we treat the condition? What should out approach to biomarkers be? What are we looking for when it comes to urine output? Make sure you check out POQI's website here: https://www.thepoqi.org/ While you're online why not book tickets for the next EBPOM conference: www.ebpom.org Presented by Andy Shaw, Chairman, Department of Intensive Care and resuscitation at The Cleveland Clinic, Fellow of the Royal College of Anaesthetists (UK), the American College of Critical Care Medicine and the Faculty of Intensive Care Medicine (UK), Mike Grocott, Professor of Anaesthesia and critical care at the University of Southampton, John Prowle, Senior clinical lecturer, intensivist nephrologist, Royal London Hospital in East London, Marlies Ostermann, Consultant in critical care and nephrology, Guy's and St Thomas's NHS Foundation Trust and Sandy Kane-Gill, Professor, Pharmacy and Theraputics, Univeristy of Pittsburgh School of Pharmacy.

Tim Read, M.D., is a psychiatrist and psychotherapist, with degrees in neuroscience and medicine. After heading the services for psychiatric emergencies and crisis intervention at the Royal London Hospital for 20 years, he is now involved in clinical research at King's College and Imperial College, London University, on the therapeutic use of psychedelics. He has completed training in psychoanalytic psychotherapy and transpersonal psychology with Stanislav Grof and is a certified holotropic breathwork facilitator. The author of Walking Shadows and co-author of Breaking Open, he lives in London.Maria Papaspyrou, MSc, is an integrative psychotherapist, supervisor, and family constellations facilitator. She has given talks and published articles on entheogens' sacramental and healing properties, supporting their re-introduction in psychotherapy. The co-editor of Psychedelic Mysteries of the Feminine, she lives in Brighton, England. Together, the authors are co-directors of the Institute of Psychedelic Therapy in the UK.'It's the relationship that heals as opposed to the specific therapeutic technique, and it's what we bring from our personal depths to that relationship that makes all the difference.' ~Tim ReadFor more information on the Well of Light Global Community, Programs, Radio shows and Services go to www.welloflight.comTo access other great interviews and offerings: www.patreon.com/welloflightYour donations are gratefully received and make it all possible!

Positive results for a handful of patients on a trial in the United States offers hope for the millions of people around the world living with sickle cell disease. Doctors say the gene-editing therapy literally 'turns back the clock' by reducing the number of red blood cells that are sickle-shaped and increasing the type that a baby has, which can carry more oxygen around the body. Other cheaper, more widely-available medications can work, but we hear how the health of sickle cell patients depends on where they live. After two years of caring for patients with Covid-19, many healthcare workers are exhausted. This week's guest, Graham Easton, who is Professor of Communication Skills at Barts and The Royal London Hospital, explains how mistakes can happen when doctors carry out repetitive tasks when they are tired. Could changing your asthma inhaler be better for you and the planet? We hear from Caroline and her son Sebastian, who found that switching to dry-powder inhalers transformed their lives. Presenter: Claudia Hammond Producer: Paula McGrath and Samara Linton (Picture: Scientist analysing a blood sample in a laboratory. Photo credit: Krisanapong Detraphiphat/Getty Images.)

Dr Michael Mew qualified in the 1993 as a dentist at the Royal London Hospital. After several years in general practice, community dentistry and facial surgery, he entered the renowned Orthodontic programme at Aarhus University in Denmark, qualifying as a specialist dentist in 2004. He is particularly interested in the cause of crooked teeth and the Aetiology of Malocclusion, he feels that when the profession understands so little, it is best to start at the bottom and work up.Find his website at https://orthodontichealth.co.uk/about/Find his YouTube channel at https://www.youtube.com/c/Orthotropics/***TIMESTAMPS***0:00 - Intro2:45 - Mike Mew's background and controversial idea: mewing7:40 - Why do we have crooked teeth?13:20 - James Nestor and the book, Breathe, and hypothesis on jaw structure and mouths18:00 - Orthodontics community strong dislike for Dr. Mike Mew's concept; my issues with my orthodontist experience31:00 - Dr. John Mew and the current state of mewing and what needs to be done to continue the exposure 34:00 - How to Mew 54:00 - Will newer generations want to continue this change in dentistry? Why are people working jobs they hate for purely material gain?59:00 - Why Mewing isn't a revolutionary idea and how this goes back to manners 1:04:00 - Issues with trying to get a breakthrough with this theory; the setbacks and difficulty with attempting to expose these ideas1:12:00 - Jawzercise and Chiseled, not a gimmick! 1:18:00 - Sleep Apnea and killing 20% of people in their 60's1:24:08 - Outro~YouTube EPISODES:https://www.youtube.com/channel/UCyLKzv5fKxGmVQg3cMJJzyQ/videos~Song provided by: Ayush Garg

Natasha's guest this week is an embodiment coach, Rachel Bednarski and in the conversation they dissect the term ‘embodiment' to help you realise just how beneficial it is for your health to have a regular practice. Have you heard of embodiment? It is word you might hear a lot but not fully understand it's meaning. Perhaps you are already embodying daily practises and want to get deeper into understanding how it can benefit you.What are the practises you can have or can integrate into your life to bring you back to your innate wisdom and personal magic? In this weeks episode Natasha talks about the Felt Sense meditations she offers FREE twice a month - sign up below and we'll make sure you get a reminder. I'd love to know what your favourite embodiment practises are? How do they help you? Rachel mentions the doctor she was referred to and his details can be found below:Dr Roniger and Royal London Hospital for Integrative Medicinehttps://www.uclh.nhs.uk/our-services/our-hospitals/royal-london-hospital-integrated-medicineJoin my for my FREE fortnightly Felt Sense meditation session by signing up here.About Rachel:Rachel is a women's embodiment and certified Spiritual Life coach, working with sensitive & overwhelmed women to guide them back to their inner power through embodied practices of breathwork, yoga, movement, energy healing, meditation, Tantric practices & inner work. She is also a copywriter, helping small businesses & creative entrepreneurs in the wellness industry to get their voice out & their messages to the people who need to hear them.You can find Rachel at:Website: https://www.rachelbednarski.com/Facebook: https://www.facebook.com/rachelbednarskiwriterInstagram: https://www.instagram.com/rachelbednarski_/ About Natasha:Natasha de Grunwald is a subconscious transformation coach, a mentor, a teacher, trainer, breathwork facilitator and a Mum to a 19 year old daughter. She has been teaching and training and holding space for people in the wellness industry for over 30 years.To sign up for my newsletter you can click hereFind me at:Website: www.natashadegrunwald.co.ukFacebook: https://www.facebook.com/londonthaiyogaInstagram: https://www.instagram.com/thaiyogamassage/

The Perioperative Quality Initiative (POQI) focuses upon renal injury. How do we identify patients early? How do we treat the condition? What should out approach to biomarkers be? What are we looking for when it comes to urine output? Make sure you check out POQI's website here: https://www.thepoqi.org/ While you're online why not book tickets for the next EBPOM conference: www.ebpom.org Presented by Andy Shaw, Chairman, Department of Anesthesiology and Pain Medicine at The University of Alberta, Alberta and Zone Clinical Department Head for Anesthesia, Alberta Health Services Edmonton Zone, a Fellow of the Royal College of Anaesthetists (UK), the American College of Critical Care Medicine and the Faculty of Intensive Care Medicine (UK), Mike Grocott, Professor of Anaesthesia and critical care at the University of Southampton, John Prowle, Senior clinical lecturer, intensivist nephrologist, Royal London Hospital in East London, Marlies Ostermann, Consultant in critical care and nephrology, Guy's and St Thomas's NHS Foundation Trust and Sandy Kane-Gill, Professor, Pharmacy and Theraputics, Univeristy of Pittsburgh School of Pharmacy.

Dr Alex learns more about what it's been like to work as a nurse in adult critical care through the Covid-19 crisis with Senior Sister Becky Ellis-Smith from the Royal London Hospital.   Caring for the sickest patients, with case numbers increasing through the second wave, Becky talks honestly about the kind of pressures staff are facing as they are pushed to the limit.   Content warning: contains references to intensive care trauma and treatments, maternal death, losing a baby, death, bereavement, mental health   In the UK, the Samaritans can be contacted on 116 123. In the US, the National Suicide Prevention Hotline is 1-800-273-8255. In Australia, the crisis support service Lifeline is on 13 11 14. Hotlines in other countries can be found here.   If you want to get in touch, please email askdralexgeorge@gmail.com   For more information on Frontline19   Thanks to Co op Health for sponsoring this series of The Waiting Room. Don't forget to download the Co op Health app today.

In this edition, you can listen to the second half of my interview with Dr. Munir Ravalia where we share with you a case study and some great tips to improve patient experience and overall results. Dr. Ravalia is an oral sedation specialist, medical/clinical hypnotherapist and a clinical lecturer on conscious sedation at the Royal London Hospital, offering sedation services in the UK.  Please enjoy this episode and when you do... I would love to read your honest review, here or wherever you listen to The Natural Comfort Specialist weekly! Thanks for listening. Until next week.